.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has shown consistent performance in the Alberta market, particularly in the Capsules category where it maintained a solid third-place ranking from April to July 2025. Despite a decline in sales from $102,370 in April to $82,831 in July, the brand's ranking stability suggests a loyal customer base. In the Concentrates category, however, Stigma Grow's ranking fluctuated, moving from 15th in April to 18th in July, indicating potential challenges in maintaining market share. The brand did not make it into the top 30 for the Flower category in Alberta, which might suggest an area for growth or a need for strategic adjustments.
In British Columbia, Stigma Grow's performance in the Capsules category was notable in April and May, securing a 9th-place ranking before falling out of the top 30 by June. This drop could point to increased competition or shifting consumer preferences. Conversely, in the Concentrates category, the brand showed resilience, improving its ranking from 19th in April to 17th by July, despite experiencing a dip in sales in June. Meanwhile, in Ontario, Stigma Grow maintained a steady position in the Capsules category, consistently ranking 8th or 9th throughout the months, which indicates a stable presence in this market segment. However, their absence from the top 30 in the Concentrates category after April suggests a need to reassess their strategy in this area.
Competitive Landscape
In the Alberta capsules market, Stigma Grow has consistently maintained its position as the third-ranked brand from April to July 2025. Despite stable rankings, Stigma Grow faces significant competition from top brands like Tweed and Glacial Gold, which have held the first and second ranks, respectively, throughout the same period. Tweed's sales are notably higher, consistently leading the market, while Glacial Gold also outpaces Stigma Grow with a steady increase in sales. Meanwhile, Emprise Canada and Frank have shown fluctuations in their rankings but remain behind Stigma Grow. This competitive landscape suggests that while Stigma Grow maintains a solid position, there is room for growth, particularly in increasing sales to close the gap with the leading brands.
Notable Products
In July 2025, the top-performing product from Stigma Grow was Indica RSO Capsules 25-Pack (250mg), maintaining its position as the number one ranked product for four consecutive months, with sales of 3841 units. Phoenix Tears RSO (1g) consistently held the second position each month, showing a slight increase in sales from June to July. CBD Softgels 15-Pack (750mg CBD) remained steady at the third rank, with sales figures stabilizing after a dip in June. Twisted Citrus (14g) made its debut in July, securing the fourth position, while Grape Limeade (14g) followed closely at fifth. These rankings highlight a stable performance for the top three products, with new entries in the flower category showing potential growth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
